Recent Comments

Comment RSS

Wellbutrin News and Research RSS Feed - Wellbutrin News and Research

Wellbutrin is a prescription medicine used to treat adults with a certain type of depression called major depressive disorder and for prevention of autumn-winter seasonal depression (seasonal affective disorder).

Third-quarter financial results for the year 2009 announced by Biovail

5. November 2009 08:02
Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company’s current views, and actual outcomes are not certain. [More]

Posted in: Business / Finance

Tags: , , , , , , ,

Permalink | Comments (0)

Biomarkers for rapid identification of treatment effectiveness in major depression

11. September 2009 03:55
Now, based on the final results of a nationwide study led by UCLA, clinicians may be able to accurately predict within a week whether a particular drug will be effective by using a non-invasive test that takes less than 15 minutes to administer. The test will allow physicians to quickly switch patients to a more effective treatment, if necessary. [More]

Posted in: Device / Technology News | Medical Condition News

Tags: , , , , , , , , , , ,

Permalink | Comments (1)

Report on prescription drugs in worldwide markets

9. September 2009 05:03
Reportlinker.com announces that a new market research report is available in its catalogue. Prescription Drugs [More]

Posted in: Pharmaceutical News

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Permalink | Comments (0)

Biovail's patent infringement lawsuit against Cary Pharma may affect IntelGenx revenues

24. August 2009 00:07
IntelGenx Corp. (TSX VENTURE:IGX)(OTCBB:IGXT) ("IntelGenx") previously announced that the New Drug Application (NDA) filing for the antidepressant CPI-300, which it developed with Cary Pharmaceuticals ("Cary Pharma") had been accepted by the U.S. Food and Drug Administration (FDA) for standard review. CPI-300 is a novel, high strength of Bupropion HCl, the active ingredient in Wellbutrin XL®. [More]

Posted in: Medical Patent News | Pharmaceutical News

Tags: , , , , ,

Permalink | Comments (0)

Chantix and Zyban to get boxed warnings on serious mental health events

1. July 2009 21:56
The U.S. Food and Drug Administration has announced that it is requiring manufacturers to put a Boxed Warning on the prescribing information for the smoking cessation drugs Chantix (varenicline) and Zyban (bupropion). The warning will highlight the risk of serious mental health events including changes in behavior, depressed mood, hostility, and suicidal thoughts when taking these drugs. [More]

Posted in: Pharmaceutical News

Tags: , , , , , , ,

Permalink | Comments (0)

GSK to divest U.S. rights for Wellbutrin XL to Biovail

6. May 2009 06:16
GlaxoSmithKline has announced that it has entered into an agreement to divest full commercial rights to Wellbutrin XL in the United States to Biovail International Laboratories SRL, a subsidiary of Biovail Corporation, for $510 million (euro 340 million). The agreement is subject to Hart-Scott-Rodino regulatory clearance in the United States. [More]

Posted in: Pharmaceutical News

Tags: , ,

Permalink | Comments (0)

New antidepressants might be no more effective than the best existing drugs

5. May 2009 20:51
The reviews suggest that sertraline - sold under the brand name Zoloft since 1991- could be the best initial choice of antidepressant in people with acute major depression. The generic formulation produced the best balance of effectiveness, tolerability and purchase price, the authors say. [More]

Posted in: Pharmaceutical News

Tags: , , , , , , , , , , , , ,

Permalink | Comments (1)

Happy pills in America -- Our complex love affair with designer consciousness

19. March 2009 18:38
The spectacular increase in the use of psychiatric drugs over the past 50 years involved what a University at Buffalo historian calls "a massive break with what we consider 'normal' mental health," one linked to myriad social and cultural changes in America. [More]

Posted in: Pharmaceutical News

Tags: , , , , ,

Permalink | Comments (0)

Watson Pharmaceuticals receives FDA approval for generic Wellbutrin XL

26. November 2008 22:59
Watson Pharmaceuticals, Inc. has announced that its subsidiary, Watson Laboratories, Inc., has received final approval today from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets (XL) in the 150 mg strength. [More]

Posted in: Pharmaceutical News

Tags: , ,

Permalink | Comments (0)

Actavis receives approval of generic Wellbutrin in U.S.

18. August 2008 17:27
Actavis Group today announced that it has received approval from the U.S. Food & Drug Administration to market Bupropion Hydrochloride extended-release tablets (XL) 300mg. Distribution of the product will commence immediately. [More]

Posted in: Pharmaceutical News

Tags: ,

Permalink | Comments (0)

Chantix for smoking cessation performs better than placebos

14. July 2008 17:25
Six treatments for smoking cessation perform better than placebos - including varenicline (Chantix), recently approved for use in Canada - states a team of researchers from McGill University and the University of Montreal in an article published in Canadian Medical Association Journal. [More]

Posted in: Drug Trial News

Tags: , , , , , , , , , ,

Permalink | Comments (0)

When your antidepressants don't work

26. March 2008 07:01
should you switch to a different medication from the same class or should you try an antidepressant medication that has a different mechanism of action? [More]

Posted in: Drug Trial News

Tags: , , , , , , , , , ,

Permalink | Comments (0)

Antidepressants might be worthless for treating low back pain

30. January 2008 02:26
The review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic. [More]

Posted in: Drug Trial News

Tags: , , , , , , , , , , , , , ,

Permalink | Comments (0)

Selective publication means unfavorable drug studies rarely get published

20. January 2008 20:36
A new report claims that almost a third of the research done on antidepressant drugs is never published in medical literature and most of those unpublished reports are unfavorable. [More]

Posted in: Pharmaceutical News

Tags: , , , , , ,

Permalink | Comments (0)

FDA - all antidepressants need new warning labels

3. May 2007 06:48
The Food and Drug Administration (FDA) in the United States wants the manufacturers of antidepressant medications to change the labels on their products. [More]

Posted in: Pharmaceutical News

Tags: , , , , , , , ,

Permalink | Comments (0)
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.